NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,247,581 | +57.0% | 12,248 | -56.6% | 0.02% | +72.7% |
Q2 2023 | $794,835 | -74.1% | 28,248 | +46.7% | 0.01% | -79.2% |
Q1 2023 | $3,065,092 | +565.8% | 19,260 | +279.5% | 0.05% | +562.5% |
Q4 2022 | $460,374 | -49.6% | 5,075 | -53.0% | 0.01% | -61.9% |
Q2 2022 | $913,000 | +27.3% | 10,800 | +32.2% | 0.02% | +31.2% |
Q1 2022 | $717,000 | -3.4% | 8,169 | -3.7% | 0.02% | -11.1% |
Q4 2021 | $742,000 | +12.3% | 8,484 | +5.0% | 0.02% | 0.0% |
Q3 2021 | $661,000 | -0.6% | 8,078 | +10.8% | 0.02% | 0.0% |
Q2 2021 | $665,000 | +20.5% | 7,288 | +12.8% | 0.02% | 0.0% |
Q1 2021 | $552,000 | -9.1% | 6,462 | +0.5% | 0.02% | -14.3% |
Q4 2020 | $607,000 | -6.6% | 6,428 | -14.0% | 0.02% | -25.0% |
Q3 2020 | $650,000 | +13.6% | 7,471 | +14.1% | 0.03% | +16.7% |
Q2 2020 | $572,000 | -12.7% | 6,550 | -17.6% | 0.02% | -25.0% |
Q1 2020 | $655,000 | -10.8% | 7,949 | +2.6% | 0.03% | +6.7% |
Q4 2019 | $734,000 | +6.4% | 7,747 | -2.4% | 0.03% | -11.8% |
Q3 2019 | $690,000 | +25.5% | 7,938 | +31.7% | 0.03% | 0.0% |
Q2 2019 | $550,000 | +135.0% | 6,026 | +147.2% | 0.03% | +54.5% |
Q1 2019 | $234,000 | +13.0% | 2,438 | +1.0% | 0.02% | +37.5% |
Q4 2018 | $207,000 | -97.8% | 2,415 | -98.2% | 0.02% | -98.9% |
Q1 2016 | $9,471,000 | -20.7% | 130,738 | -5.9% | 1.45% | -27.7% |
Q4 2015 | $11,950,000 | -5.4% | 138,885 | +1.1% | 2.01% | -16.6% |
Q3 2015 | $12,630,000 | -99.9% | 137,402 | -0.5% | 2.41% | -5.3% |
Q2 2015 | $13,573,681,000 | +1.6% | 138,028 | +1.8% | 2.54% | +1.2% |
Q1 2015 | $13,364,471,000 | +105298.0% | 135,529 | -1.0% | 2.51% | +20.2% |
Q4 2014 | $12,680,000 | -1.6% | 136,849 | -0.0% | 2.09% | +0.1% |
Q3 2014 | $12,887,000 | +8.2% | 136,902 | +4.1% | 2.09% | -24.6% |
Q2 2014 | $11,909,000 | +8.8% | 131,548 | +2.2% | 2.77% | -7.5% |
Q1 2014 | $10,941,000 | +8.1% | 128,686 | +2.2% | 2.99% | +13.9% |
Q4 2013 | $10,124,000 | +7.9% | 125,957 | +3.0% | 2.63% | -10.9% |
Q3 2013 | $9,380,000 | +13.1% | 122,279 | +4.2% | 2.95% | -1.5% |
Q2 2013 | $8,296,000 | – | 117,325 | – | 2.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |